MedPath

Citrulline

Generic Name
Citrulline
Drug Type
Small Molecule
Chemical Formula
C6H13N3O3
CAS Number
372-75-8
Unique Ingredient Identifier
29VT07BGDA

Overview

Citrulline is an amino acid. It is made from ornithine and carbamoyl phosphate in one of the central reactions in the urea cycle. It is also produced from arginine as a by-product of the reaction catalyzed by NOS family. Its name is derived from citrullus, the Latin word for watermelon, from which it was first isolated.

Indication

Used for nutritional supplementation, also for treating dietary shortage or imbalance.

Associated Conditions

No associated conditions information available.

Research Report

Published: Aug 26, 2025

A Comprehensive Pharmacological and Clinical Monograph on L-Citrulline (DB00155)

Executive Summary

L-Citrulline is a non-proteinogenic α-amino acid with a unique and multifaceted role in human physiology. While endogenously synthesized, its therapeutic and supplemental applications stem from a distinctive pharmacological profile, primarily its function as a highly bioavailable precursor to L-arginine. This report provides an exhaustive analysis of L-Citrulline, synthesizing its chemical properties, metabolic pathways, clinical pharmacology, therapeutic efficacy, and safety profile.

A central finding of this monograph is the "Citrulline Paradox": oral administration of L-citrulline is a more effective strategy for increasing systemic L-arginine levels than supplementing with L-arginine itself. This is due to L-citrulline's ability to bypass the extensive first-pass metabolism in the gut and liver that significantly limits L-arginine's bioavailability. This superior pharmacokinetic profile is the foundation for its clinical applications, which are primarily mediated by the subsequent enhancement of the L-arginine-nitric oxide (NO) pathway.

Continue reading the full research report

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/05/25
Phase 3
Not yet recruiting
2024/10/10
Phase 2
Recruiting
Suvankar Majumdar
2024/03/15
Phase 1
Recruiting
2024/01/19
Phase 3
Not yet recruiting
University Hospital, Grenoble
2022/03/02
Phase 2
Recruiting
2022/02/23
Phase 3
Recruiting
2021/07/28
Phase 1
Suspended
2021/04/21
Phase 1
Recruiting
2020/09/30
Phase 2
Completed
2019/05/16
Phase 1
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Perdido Key Health and Wellness Inc
70104-128
INTRAMUSCULAR
1 mg in 1 mL
11/23/2015

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.